Shwachman-Diamond Syndrome (SDS) is an autosomal recessive disease (#260400) characterized
by pancreatic exocrine insufficiency, haematological abnormalities (neutropenia and anaemia), bone marrow failure (with increased risk for acute myeloid leukaemia (AML) or myelodysplasia (MDS) and skeletal alterations.
As suggested by international guidelines 1 , the SDS clinical diagnosis is confirmed by detection of bi-allelic pathogenic variants in SBDS gene, localized at 7q11.21 2, 3 .
Targeted mutation analysis of exon 2 by PCR_RFLP discloses in at least 90% of SDS patients one of the three common mutations, (c. Western-blot analysis using SBDS antibody did not demonstrate any SBDS protein in these patients, suggesting the presence of a more complex anomaly on the second allele ( Fig. 1 ).
We performed a deletion/duplication analysis by long-range gDNA PCR with the specific primers designed as Boocock et al. 2 , but matching them differently to obtain longer amplicons containing more exons. When using the following primers [forward for exon 2] and [reverse for exon 4], that amplify the region from exon 2 to exon 4, we observed in both index cases the expected band of 3756 bp and the presence of a second smaller band of approximately 3000 bp (Fig. 2) .
We then extracted the DNA from the smaller band and used it as template in a new long-range PCR experiment, with the same primers as before. Direct sequencing of PCR product demonstrated a deletion of exon 3; breakpoints at 5' and 3' are located, respectively, in intron 2 and in intron 3.
The coordinates of the deleted region in GRCh37/hg19 assembly are chr7: g.66457801-66458666, with a deletion size of 866 bp. According to nomenclature for sequence variations 4 , we describe the mutation as [c.258+533_459+403del] . The presence of the mutation was confirmed in the father of UPN 42/43 and in the mother of UPN 61/76.
The two families we studied are unrelated, the family names of the two parents carrying the deletion of exon 3 are uncommon in Italy, and have their higher incidence in different Italian areas, far apart from each other, as Sicily and Lazio; available evidence suggest that the mutations arose independently in the two families.
In the 92 index cases known to the Italian registry, mutations other than the common ones are 14, only one of them [c.187G>T; p.G63C], damaging according to the prediction tools POLYPHEN 2 and SYFT, was observed twice but the two families originate from the same area (Tuscany).
Therefore, the mutation we report is the second one (different from the common ones) that is present twice in the Italian population, in 2 out of 184 pathogenic alleles.
Costa et al. 5 , described the only case reported so far of a large deletion, paternally inherited, removing exon 3; they hypothesized that the deletion derived from an excision event mediated by the AluSx elements which are present in introns 2 and 3. The authors extensively discussed the mechanism of origin of the deletion, underlined that there is a 80% of homology between intron 2 and 3 of the gene, that breakpoints are within AluSx elements, close to a 21 bp tract of completely homologous sequence. They conclude that the likely mechanism is "a mispairing of homologous sequences and unequal crossing over between introns 2 and 3 of SBDS gene".
The deletion observed in our cases overlaps, but not completely, with the one reported by Costa et al.
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. We aligned (BLAST sequence analysis tool) full sequences of intron 2 and intron 3 of SBDS and SBDSP1 and the sequences of the 21 bp tracts present in both intron 2 and 3.
We found a high level of homology between intron 2 and intron 3 in SBDS and SBDSP1 (95% for intron 2, and 94% for intron 3), while the level of homology for the three 21 bp tracts present in both intron 2 and 3 between gene and pseudogene ranged from 95,2% to 98,4%.
Carvalho et al. 6 reported an uncommon SDS genotype in a white/Hispanic female: a rare mutation [c.98A > C; p.K33T] was associated to a large insertion of an unknown segment near 5' of intron 1 or 2 in the SBDS gene.
When discussing the origin of the insertion, they suggested that it arose from non-homologous allelic recombination (NAHR) between SBDS and the closely located SBDSP1 pseudogene.
This statement was based on the evidence that the SBDSP1 shares 97% identity with SBDS and is in an inverted orientation in a closely duplicated genomic segment. Such a structure may result in genomic instability and enhance the chance of NAHR and inversion structural variation (SV).
Significantly, SBDS is one of the 31 disease-associated genes identified intersecting in a genomewide analysis the location of the inverted repeats with information for gene localisation on chromosomes 7 . Other examples of diseases in which these SV are common include Hunter syndrome (IDS gene and its telomeric pseudogene IDSP1) and hemophilia A (factor VIII gene).
These data are in keeping with the high frequency of gene conversion events in generating the common pathogenic alleles found in SDS patients, and in general, the possibility of NAHR associated to the presence inverted paralogous-low copy repeats (IP-LCRs), should be considered when, for the previously quoted diseases, routine molecular testing does not immediately identify a surely pathogenic mutation.
Thus in the two unrelated families we report, this mechanism is the most likely to generate the deletion of exon 3.
Kuijpers et al. 8 and Donadieu et al 9 report failure to identify pathogenic sequence variations respectively in 5/20 and 2/104 case, whose clinical picture seemed well consistent with the diagnosis of SDS.
Therefore, it is now our policy to perform Western blotting analysis and a search for genomic rearrangements in all cases in whom a reliable clinical diagnosis is not followed by evidence of biallelic mutations.
